Retatrutide 40mg Triple Agonist Research Peptide UK — Lab Tested, Fast Dispatch

Retatrutide 40mg (CAS No. 2381089-83-2) is a premium-quality synthetic peptide formulated for advanced metabolic and obesity-related research. As a novel triple hormone receptor agonist, Retatrutide simultaneously activates GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and glucagon receptors, making it one of the most innovative compounds under investigation in peptide science.

Each vial contains 40mg of highly purified Retatrutide, typically manufactured to a purity standard of 99% or higher and verified through HPLC and mass spectrometry testing. Researchers utilize Retatrutide in studies exploring energy expenditure, body weight regulation, insulin sensitivity, and metabolic function. The product is supplied as a stable lyophilized powder and should be stored at −20°C for optimal preservation.

CAS Number: 2381089-83-2

Disclaimer:
Retatrutide remains an investigational research compound and is not currently approved for human therapeutic use in the UK. Products available through research suppliers are intended strictly for laboratory and scientific research purposes.